Zdrowie i gospodarka · 14/07/2021

FDA Clears Path for Ivermectin Tablets to be Approved via Abbreviated New Drug Application

The US Food and Drug Administration (FDA) has made a determination that STROMECTOL (ivermectin) tablets, 6 milligrams, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications for these tablets.